Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Novartis Ireland Limited .
Filed returns
6
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2025 | Novartis Ireland Limited | Health | Advocate for Life Science Strategy (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2024 | Novartis Ireland Limited | Health | Implementation of SMA testing into the heel prick test for newborns (Matters involving public funds) | 7 | On lobbying.ie |
| May–Aug 2024 | Novartis Ireland Limited | Health | Newborn screening for spinal muscular atrophy (SMA) is implemented for babies in Ireland (Matters involving public funds) | 25 | On lobbying.ie |
| Jan–Apr 2023 | Novartis Ireland Limited | Health | The Pharma Industry in Ireland ask for government support to reform the reimbursement process as Irish patients lagging behind EU counterparts in terms of access to medicines (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2019 | Novartis Ireland Limited | Health | Timely access to innovative new medicines (Matters involving public funds) | 2 | On lobbying.ie |
| May–Aug 2016 | Novartis Ireland Limited | Health | Ensure that the 2016 Framework Agreement on the Pricing and Supply of Medicines is resolved by aggreement, not legislation (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 6 | 100.0% |